In this study, CTCs were classified into EMT subtypes using the CanPatrol system, and the expression of the molecular marker L1CAM was assessed to systematically evaluate their relationship with lymph node metastasis in breast cancer. The gene discussed is L1CAM; the disease is metastatic malignant neoplasm in the lymph nodes.